Biomedical Systems Forms Strategic Partnership with RadMD

Wednesday, April 12, 2017

Biomedical Systems – an over 40-year-old, leading clinical trial provider to pharmaceutical, medical device, biotech, and contract research organizations (CROs) announced a strategic partnership with RadMD, a global provider for independent expert physician image reviews for both safety and efficacy endpoints.

We are excited about this partnership as it allows us to fully leverage the significant expertise prevalent in the RadMD organization. Their organization of over 600 experts comprised of Radiologists, Oncologists, Cardiologists, Pathologists, Dermatologists, Gastroenterologists, Wound Healing Experts, Vascular Surgeons, and Medical Imaging Physicists will certainly enable us to provide our clients a superior imaging clinical trial experience. This step forward is particularly important, given the persistent increase in oncology trials and the continued reliance on imaging services for efficacy evaluations. Independent expert readers such as those from RadMD represent a vital component to providing our clients with consistent and reliable data, said Bob Mills, CCO, Biomedical Systems.

The agreement will enable the two organizations to further collaborate on clinical trials and will facilitate a more integrated approach to the execution of the imaging reads. Additionally, this alliance will bolster each organizations’ imaging capabilities, ultimately benefitting sponsors.

Biomedical Systems has long been known for their dedication to high quality operations. Their continued growth is a testament to this dedication. The agreement between our organizations establishes a new level of comprehensive reader management by RadMD, leveraging our team of BRITI-certified (BRITI – Blinded Reader and Investigator Training Institute) readers. Our organization will also handle study-specific training and performance management throughout the trial, said Rick Patt and Kohkan Shamsi, Cofounders and Principals of RadMD. Further, all of our readers are fellowship-trained disease experts, which is the most critical element of their qualifications. This expertise combined with BMS’ advanced electronic case report forms (eCRFs) will raise the bar on the quality of image interpretations in clinical trials.

TOP